ArticleAngewandte Chemie (International ed. in English)2025
Unveiling an Alternative Mechanism for Lewis Basic Selenium as a C─H Hydrogen Bond Catalyst and Its Application in the Halogenation of Arenes.
Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- α-C(spOrganic letters · 2026Article
- Selenium-catalyzed organic transformations.iScience · 2026Review
- Unveiling an Alternative Mechanism for Lewis Basic Selenium as a C─H Hydrogen Bond Catalyst and Its Application in the Halogenation of Arenes.Angewandte Chemie (International ed. in English) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Electrophilic halogenation is a fundamentally useful transformation, and Lewis basic selenium catalysts together with N-haloimides are known to promote the reaction under mild conditions. Selenourea is a frequently used platform for the Lewis base catalyst design. In literature, it is generally believed that the Lewis basic selenium can form a Lewis adduct with the halogen as the active halogenating species. Herein, we report our recent finding that unveils an alternative mechanism of this type of reaction. It was found that the Lewis basic selenourea is first oxidized by the halogen source to give a benchtop stable and non-hygroscopic imidazolium hypervalent selenium dibromide compound that acts as the actual catalyst. The negative charge in the hypervalent selenium compound is stabilized by the electronegative bromide, leading to the site-isolated and unoccupied imidazolium cationic moiety. Mechanistic studies suggest that the electropositive C-Hs of the imidazolium cation can act as a strong hydrogen bond donor to activate the N-haloimide reagent for efficient halogenation reaction, including late-stage halogenation of drug molecules, with low catalyst loading. Further study revealed that hypervalent imidazolium selenium dibromide can generally be applied to other mechanistically unrelated hydrogen bond-catalyzed reactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.